Market prioritisation is a portfolio decision, not a TAM ranking

Most market-prioritisation exercises have a disguised winner. It is the option with the largest total addressable market. The number may be carefully calculated, beautifully presented, and still answer the wrong question.

The question is not, which market is largest? It is, which option deserves the next unit of attention, capital, capacity, or learning effort under a declared decision horizon? Those are not the same question. A large market can be difficult to reach, expensive to serve, poorly measured, or badly matched to the firm’s current capabilities. A smaller option can deserve the next test because it resolves an important uncertainty at a reversible cost.

Market prioritisation is therefore a portfolio decision, not a TAM ranking. It compares defined market or segment options under one decision, one horizon, one scarce resource, and an explicit stopping condition. The output is not a universal score. It is a sequence of choices: screen, learn, commit, constrain, or stop.

That distinction starts where the TAM-to-budget boundary ends. A market-size number can define an opportunity. It does not choose among the opportunities that compete for the same finite system.

How should commercial leadership define strategic priority before ranking markets?

The word priority hides the decision. First to research is not first to fund. First to test is not first to scale. First to enter is not first to build a permanent operating base. If the decision is not named, the portfolio will quietly optimise for the easiest number to compare.

Write five fields before comparing options:

1. Decision. Are you choosing the next research sprint, pilot, launch, investment, or scale commitment?
2. Horizon. Over what period does the option consume resources and produce an outcome?
3. Scarce resource. Is the constraint cash, seller time, implementation capacity, management attention, technical support, or information work?
4. Market object. What buyer, use, geography, unit, date, price basis, and boundary are being compared?
5. Exit condition. What observation would constrain, pause, redirect, or stop the option?

The fifth field prevents a priority from becoming a one-way promise. It also keeps reversibility visible. Reversibility does not mean that an option can be abandoned at zero cost. It means the decision record asks what can be redirected, what remains committed, and what relationship, capability, or reputation costs an exit would leave behind.

Why is theoretical market potential distinct from an actionable firm option?

Goodman separates market potential from a sales forecast. Potential describes an opportunity or environmental state. A forecast describes an expectation conditional on marketing decisions (Goodman, 1972). The distinction matters twice in a portfolio.

First, a potential estimate tells you something about the environment. It does not tell you what a particular firm can reach with its offer, route, proof, capacity, price, and service model. Second, two options can have equally large potential and require radically different evidence before a decision is safe. The number is not wrong because it is broad. It is wrong only when the portfolio asks it to carry a narrower conclusion than it contains.

Goodman’s treatment also keeps the measurement process beside its limitations. Industrial market measurement may rely on aggregate data, building blocks, proxies, and assumptions constrained by what is available (Goodman, 1972). A portfolio that stores only the result loses the reason one option is more certain than another.

That is why the first comparison should not be TAM A versus TAM B. It should be: what does the evidence for A measure, what does the evidence for B measure, and what decision could either support?

Which structural layers compose a rigorous market attractiveness assessment?

Natarajarathinam and Nepal offer a useful, bounded sequence for a company considering expansion. It moves from country market potential to company-specific sales potential and then to return on investment (Natarajarathinam & Nepal, 2012). The stages use different external, internal, capability, resource, and investment conditions (Natarajarathinam & Nepal, 2012).

This is not a universal market-ranking formula. The authors illustrate it with a fastener manufacturer assessing Mexico (Natarajarathinam & Nepal, 2012). The case is valuable because it shows the layers that a ranking usually hides:

• Market potential: what the defined environment appears to contain.
• Firm sales potential: what this offer and this firm could reach under stated conditions.
• Investment burden: what people, facilities, delivery, service, working capital, time, and management attention the option consumes.
• Return decision: whether the resulting cash flows, horizon, downside, and outcome justify the commitment.

The layers can move in different directions. A market can have strong potential but weak current firm fit. A firm can have a plausible sales scenario but insufficient delivery capacity. An option can be unattractive as a permanent investment and still be useful as a small learning test. A portfolio becomes more intelligent when those verdicts are allowed to differ.

Why does selection methodology dictate the resulting market sequence?

The measurement method is not a neutral camera pointed at a market. Waheeduzzaman compares analogy, proxy indicators, chain-ratio methods, time series, and multiple regression as alternative approaches to international market-potential estimation (Waheeduzzaman, 2008). The comparison is not precision alone. It includes precision, prediction, price, and pragmatism (Waheeduzzaman, 2008).

That gives a portfolio a practical question: what level of evidence is proportionate to the decision we are about to make? A cheap proxy can be enough to remove an obviously poor option from an early screen. It may be insufficient to authorise a capital-intensive commitment. A sophisticated model can be unnecessary when its inputs are weak or when the decision is only whether to spend one week learning.

This is not an argument for low standards. It is an argument for matching the instrument to the decision. The evidence field should name the method, its input quality, its blind spot, and the next claim it can support. A portfolio should be allowed to say unknown, worth testing without turning unknown into zero or pretending it is a negative market score.

How do metric definitions distort cross-market opportunity rankings?

Bruna’s analysis makes the measurement problem concrete from a spatial-economics angle. A domestic market-potential measure can change when the rule for internal distance or self-potential changes (Bruna, 2024). The finding concerns regional European data, not a firm’s sales forecast (Bruna, 2024).

Bruna’s conclusion is methodological: “The paper concludes that using a single rule to proxy Internal Market Potential in the same way for any sample is a bad methodology” (Bruna, 2024). That caution also applies to a commercial portfolio: a number is not self-explanatory when its construction is hidden.

The lesson is not to import the paper’s spatial method into every commercial plan. The lesson is to keep the measurement rule beside the result. If the boundary, distance treatment, price basis, or inclusion rule changes, the portfolio should record that change rather than present the new order as an objective fact.

This also explains why two market rankings can disagree without one being fraudulent. They may be answering different questions, using different boundaries, or representing internal friction differently. The right response is not to average the rankings. It is to identify which decision needs which measure.

Why must discovery and validation costs be factored into portfolio priority?

Klinger’s 1977 treatment makes a constraint easy to overlook. The research effort and information required to measure industrial market potential depend on the product’s type, age, and use (Klinger, 1977). His eight-step approach organises market-potential work for industrial products (Klinger, 1977). The framework is historical and applied, not a universal modern checklist, but the operating implication remains useful.

An option that looks attractive only after a large evidence effort is not equivalent to an option that can be screened from reliable existing data. Information work consumes scarce capacity. It may require customer classification, user identification, usage estimation, technical interpretation, competitor checks, or field validation. If that burden is invisible, the portfolio rewards options whose uncertainty is merely better hidden.

The research burden is not a reason to avoid difficult options. It is a reason to name the cost of knowing. Sometimes the correct priority is a small evidence project, not a launch. Sometimes the evidence burden is so high and the commitment so hard to reverse that the option should be constrained until a better signal exists.

How can expansion teams use market cards as an execution sequence rather than a score?

The card is deliberately wider than a ranking. Do not compress its fields into a single number unless the decision owner has declared the units, weights, evidence quality, horizon, and treatment of missing information. Even then, the underlying fields must remain visible. A score is a summary; it is not a substitute for the objects that produced it.

Start with a common evidence floor. Every option should have a defined market object and a named source or method. Then ask what the next decision actually needs.

Screen. Remove options whose boundary, buyer, unit, or date cannot be stated. This is not a judgement that the market is unattractive. It is a judgement that the current evidence cannot yet support comparison.

Learn. Choose a small, bounded test when the next uncertainty is important and the commitment can remain reversible. State the question, test cost, expected observation, owner, and review date. Learning value is the uncertainty the test may resolve. It is not a hidden revenue forecast.

Commit. Increase resources only when the evidence supports the next level of commitment and the investment burden is visible. A promising potential number is not enough if firm fit or service capacity remains unknown.

Constrain. Limit scope when the option may be useful but one condition is not yet satisfied. A constrained option can have a smaller geography, buyer group, offer, or time box. The constraint is part of the option, not an implementation detail.

Stop or redirect. Stop when the evidence contradicts the declared condition, the learning question has no useful answer, or the burden exceeds the decision’s tolerance. Redirect when a different option can resolve the same uncertainty at lower commitment.

This sequence is compatible with a mode-specific market-entry comparison, but it asks a different question. That article compares the fit between a named market and entry mode. This one decides which market or segment option deserves the next portfolio gate before a mode is selected.

Which four structural failure modes distort top-down market prioritisation?

The largest TAM goes first. This hides firm fit, service burden, and evidence quality. The largest environment may be the least reachable option under the current constraint.

A published country ranking becomes the answer. A ranking is a method-specific result for a defined date, variables, population, and decision. Reusing it for another product or firm turns a pointer into a conclusion.

Precision theatre replaces decision quality. Extra decimal places do not repair an uncertain boundary, proxy, or input. A simpler method with a visible blind spot may be better for an early screen than an elaborate model nobody can audit.

Learning is counted as a return. An experiment can create information without proving demand, profit, or a permanent right to scale. Record the uncertainty it resolves and the commitment it requires separately.

Where are the analytical boundaries of market portfolio modeling?

This article does not rank a current country, segment, or market. It does not estimate TAM, assign market share, calculate firm-specific ROI, or recommend an investment. The cited literature provides bounded market-measurement distinctions, method trade-offs, a regional measurement sensitivity, and an applied industrial research workflow. The portfolio card and staged gate sequence are author synthesis. Use them to keep a prioritisation decision auditable, not to make the evidence claim more than it contains.

References

1. Bruna, F. (2024). Market potential: The measurement of domestic market size. Letters in Spatial and Resource Sciences, 17, Article 13. https://doi.org/10.1007/s12076-024-00378-8
2. Goodman, C. S. (1972). Measuring industrial markets: Uses and limitations of available data for market measurement. Industrial Marketing Management, 3, 279-293. https://doi.org/10.1016/0019-8501(72)90020-X
3. Klinger, W. H. (1977). Measuring market potential for industrial products: An eight-step approach. Industrial Marketing Management, 6, 39-42. https://doi.org/10.1016/0019-8501(77)90031-1
4. Natarajarathinam, M., & Nepal, B. (2012). A holistic approach to market assessment for a manufacturing company in an emerging economy. Industrial Marketing Management, 41, 1142-1151. https://doi.org/10.1016/j.indmarman.2012.05.003
5. Waheeduzzaman, A. N. M. (2008). Market potential estimation in international markets: A comparison of methods. Journal of Global Marketing, 21(4), 307-320. https://doi.org/10.1080/08911760802206144